Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 181,373 | 150,795 | 119,960 | 112,157 | 86,849 |
| Accounts receivable | 54,383 | -18,013 | -32,356 | -63,604 | -27,307 |
| Other Working Capital | -97,921 | -177,054 | 9,062 | -89,884 | 61,688 |
| Other Operating Activity | 664,420 | 503,323 | 408,360 | 455,384 | 426,703 |
| Operating Cash Flow | $802,255 | $459,051 | $505,026 | $414,053 | $547,933 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95,330 | -68,710 | -62,581 | -62,219 | -58,534 |
| Net Acquisitions | -27,910 | -951,383 | -902 | -7,274 | -1,041,864 |
| Purchase Of Investment | -46,013 | -46,981 | -29,465 | -6,464 | -16,529 |
| Sale Of Investment | N/A | N/A | 0 | 3,324 | 468 |
| Purchase Sale Intangibles | -10,608 | -8,632 | -8,876 | -9,257 | -9,295 |
| Investing Cash Flow | $-179,861 | $-1,075,706 | $-101,824 | $-81,890 | $-1,125,754 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,190,000 | 1,519,230 | 350,000 | 450,000 | 1,140,000 |
| Debt Repayment | -1,284,012 | -711,745 | -1,146,242 | -545,000 | -283,694 |
| Common Stock Issued | 48,182 | 36,727 | 23,332 | 30,161 | 27,694 |
| Common Stock Repurchased | 0 | -22,844 | -53,801 | 0 | -102,058 |
| Dividend Paid | -225,093 | -211,712 | -199,497 | -186,346 | -168,130 |
| Other Financing Activity | -46,363 | -29,013 | -486 | -11,682 | -1,228 |
| Financing Cash Flow | $-317,286 | $580,643 | $-1,026,694 | $-262,867 | $612,584 |
| Exchange Rate Effect | 10,920 | -5,561 | -9,742 | 21,205 | -20,578 |
| Beginning Cash Position | 147,128 | 188,701 | 821,935 | 731,434 | 717,249 |
| End Cash Position | 463,156 | 147,128 | 188,701 | 821,935 | 731,434 |
| Net Cash Flow | $305,108 | $-36,012 | $-623,492 | $69,296 | $34,763 |
| Free Cash Flow | |||||
| Operating Cash Flow | 802,255 | 459,051 | 505,026 | 414,053 | 547,933 |
| Capital Expenditure | -105,938 | -77,342 | -71,457 | -71,476 | -67,829 |
| Free Cash Flow | 696,317 | 381,709 | 433,569 | 342,577 | 480,104 |